-
Detailed Analysis Generate Full Report Add to Watchlist
Values as of: 2025-05-05
Values as of: 2025-05-05
Currency: USD
Country : USA
Symbol | Name | Price(Change) | Market Cap |
---|---|---|---|
PSZKF | Powszechna Kasa Oszczednosci B.. |
+0.20 (+0.99%) |
USD 13.13B |
CLEGF | Coles Group Ltd |
N/A |
USD 12.70B |
IDKOF | Idemitsu Kosan Co.Ltd |
N/A |
USD 9.59B |
SHZHY | Shenzhou International Group H.. |
+0.03 (+0.35%) |
USD 9.56B |
PSHZF | Pershing Square Holdings Ltd |
+0.09 (+0.19%) |
USD 9.42B |
EFGSF | Eiffage SA |
+4.87 (+3.62%) |
USD 8.15B |
SKSUF | Sekisui Chemical Co. Ltd |
N/A |
USD 7.67B |
AZRGF | Azrieli Group Ltd |
N/A |
USD 7.63B |
OBIIF | OBIC Co.Ltd |
N/A |
USD 7.53B |
RUMOF | Rumo S.A |
N/A |
USD 7.02B |
Symbol | Name | Weight | Mer | Price(Change) | Market Cap |
---|---|---|---|---|---|
DFC:CA | 5.09 % | 0.59 % |
N/A |
N/A | |
BGC:CA | Bristol Gate Concentrated.. | 4.78 % | 0.84 % |
+0.32 (+-0.25%) |
CAD 0.02B |
DGRC:CA | CI Canada Quality Dividen.. | 4.73 % | 0.24 % |
-0.25 (-0.25%) |
CAD 0.88B |
NSCE:CA | NBI Sustainable Canadian .. | 4.52 % | 0.00 % |
+0.07 (+-0.25%) |
CAD 1.98B |
RCD:CA | RBC Quant Canadian Divide.. | 3.75 % | 0.43 % |
-0.03 (-0.25%) |
CAD 0.21B |
ZLB:CA | BMO Low Volatility Canadi.. | 3.54 % | 0.39 % |
+0.06 (+-0.25%) |
CAD 4.17B |
TQCD:CA | TD Q Canadian Dividend ET.. | 3.41 % | 0.00 % |
-0.05 (-0.25%) |
CAD 0.38B |
XMV:CA | iShares MSCI Canada Minim.. | 3.09 % | 0.33 % |
+0.21 (+-0.25%) |
CAD 0.29B |
EVOU:PA | BNP Paribas Easy ESG Equi.. | 2.04 % | 0.00 % |
+1.35 (+-0.25%) |
USD 0.01B |
VLUD:F | BNP Paribas Easy - Equity.. | 2.04 % | 0.00 % |
+1.18 (+-0.25%) |
USD 0.81M |
VLUS:F | BNP Paribas Easy - Equity.. | 2.04 % | 0.00 % |
+3.00 (+-0.25%) |
USD 9.72M |
VLUD:XETRA | BNP Paribas Easy ESG Equi.. | 2.04 % | 0.00 % |
+0.84 (+-0.25%) |
N/A |
VLUS:XETRA | BNP Paribas Easy ESG Equi.. | 2.04 % | 0.00 % |
+1.05 (+-0.25%) |
N/A |
HEW:CA | 1.88 % | 0.60 % |
N/A |
N/A |
Target Price Action | Rating Action | Analyst | Rating | Price | Date |
---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
There is nothing we particularly like
There is nothing we particularly dislike